Biologics Drug Market In Japan Gets Crowded With New Product Launches
This article was originally published in PharmAsia News
Executive Summary
Following a June launch of Takeda Pharmaceutical's Vectibix (panitumumab) for colorectal cancer, more drug makers are planning new launches for biologics drugs in Japan